嘉华国际(00173.HK)计划在港推售江门市住宅项目「J City嘉华新都汇」
嘉华国际(00173.HK)推出江门市大型住宅项目「J City嘉华新都汇」,项目分为两期「嘉瀚花园」及「嘉御花园」,总面积达36万平方米,共涉及20幢住宅共2,238个单位,以3至4房单位为主,面积介乎947至1,950平方尺,另设有特色单位,面积2,314至3,300多平方尺。
嘉华国际营业及市场策划总监(香港地产)温伟明表示,此项目是集团近年在大湾区重点打造的项目,地理位置优越,邻近江门东站。现时「嘉瀚花园」有3至4座正在开售,并已售出6至7成单位,除了国内销售外亦计划在香港推售。港人可以透过视像睇楼,并在网上进行签约,预期2021年可分阶段入伙。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.